CLINICAL TRIAL PHASE 2B - Chronic Kidney Disease
CLINICAL TRIAL PHASE 2B For Patients with Chronic Kidney Disease Stage 4
Eligibility of participation in this trial:
- 18 - 80 Years Old
- CKD stage 4 (eGFR 15- 29 > 6 Months) and Serum Creatinine 2.0 mg/ml
- Not on probiotics in the past three months
- Adherence to a low protein diet
Research Site: Lifespan Medical Services, Address: 1125 Forrest Avenue Suite 203, Dover DE 19904
Contact Email: lifespanmed@gmail.com Phone: 302-535-5405
Study Drug and Purpose: US-APR2020 is a probiotic formulation intended to restore the gut bacteria balance to improve the removal of uremic toxins in the bowel in CKD patients. This Phase 2b study is to evaluate the safety and efficacy of the probiotics in the management of patients with CKD Stage IV.
Study Regimen: You'll be given either study drug or placebo, oral, twice a day for 6 months.
Study Visit: One screening visit and 6 follow-up office visits (Day 1, 8, 30, 60, 90. And 180) that include physical exams and blood tests. Study Cost: All study drugs and tests are provided by the sponsor.
Sponsor Details: http://www.kibowpharma.com/clinicaltrials/ckdphase2